WO2005066193A1 - 左糖グルコースリピドa類縁体 - Google Patents
左糖グルコースリピドa類縁体 Download PDFInfo
- Publication number
- WO2005066193A1 WO2005066193A1 PCT/JP2005/000434 JP2005000434W WO2005066193A1 WO 2005066193 A1 WO2005066193 A1 WO 2005066193A1 JP 2005000434 W JP2005000434 W JP 2005000434W WO 2005066193 A1 WO2005066193 A1 WO 2005066193A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- compound
- decyl
- old
- phosphono
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
- C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
Definitions
- the present invention relates to a novel lipid A analog having an excellent macrophage activity inhibitory activity, and being useful as an anti-inflammatory agent, an anti-self-immune disease agent, an immunosuppressant, an antiseptic agent, or an agent for improving prognosis after coronary artery bypass graft surgery. Or a pharmacologically acceptable salt thereof, a pharmaceutical composition containing the same as an active ingredient, use of the lipid A analog or a pharmacologically acceptable salt thereof for producing the pharmaceutical composition, or a lipid A thereof.
- the present invention relates to a method for preventing or treating a disease, which comprises administering a pharmacologically effective amount of an analog or a pharmacologically acceptable salt thereof to a warm-blooded animal (particularly human). Background art
- the outermost layer of the cell wall of Gram-negative bacteria obtained from intestinal bacteria contains toxic components (endotoxin) that are not secreted outside the cells, and this endotoxin has endotoxin activity as well as living organisms. It exhibits various biological activities such as immunoadjuvant activation, macrophage activation, mitogen activation, pyrogenicity, tumor necrosis, antibody production enhancement, and TNF induction.
- Such endotoxin is composed of lipopolysaccharide, and it has been confirmed that the so-called lipid A is the active center of endotoxin activity (Imoto et al., Tetrahedron-Letters, 1985, 26, p. 15 4 5).
- Rhdobacter sphae ro ⁇ a compound found from Rhdobacter sphae ro ⁇ des as a bacterial lipid A-related compound
- Rhdobacter sphae ro ⁇ a compound found from Rhdobacter sphae ro ⁇ des as a bacterial lipid A-related compound
- An object of the present inventors is to provide a novel antiphlogistic agent, an anti-autoimmune disease agent, an immunosuppressive agent, an antiseptic agent, or a prognostic improving agent after coronary artery bypass graft surgery, which has an excellent macrophage activity inhibitory effect. Finding lipid A analogs.
- the inventors of the present invention have made intensive efforts to solve the above-mentioned problems, and as a result, an excellent macrophage activity-inhibiting effect was obtained for a compound of a class having a dalicosyl lipid A analog having a phosphono group or a phosphonoxitytyl group at position 1. And completed the present invention.
- the compounds of the present invention have made intensive efforts to solve the above-mentioned problems, and as a result, an excellent macrophage activity-inhibiting effect was obtained for a compound of a class having a dalicosyl lipid A analog having a phosphono group or a phosphonoxitytyl group at position 1. And completed the present invention.
- Q is an oxygen atom, a C, 1 C 3 alkylene group, a group—0—AI k or a group 0—AI k—0— (however, AI k represents a C, —C 3 alkylene group).
- W represents an oxygen atom or a group N H—
- R ′ (when W is S—NH—) is C, —C 2 which may be substituted with one or more groups selected from the following substituent group A.
- An alkanoyl group which may be substituted with one or more groups selected from the following Substituent Group A, a C 3 —C 20 alkenoyl group, or a C 3 -C 20 alkenyl group, which may be substituted with one or more groups selected from the following Substituent Group A Good C 3 — C 2 .
- R 1 when W is an oxygen atom, RR 3 and R 4 may be the same or different and may be substituted with a hydrogen atom, one or more groups selected from the following substituent group A, C, one C 2.
- Alkyl group, the following substituent group may be substituted with one or more groups selected from the A C 2 - C 2.
- Arukanoiru group the following substituents selected from the group A may be substituted with one or more groups C 3 one C 2.
- C 3 —C 2 which may be substituted by an alkenoyl group or one or more groups selected from the following substituent group A. Represents an alkynyl group,
- R 5 is a hydrogen atom, a halogen atom, a hydroxyl group, a C 1 -C 6 alkoxy group optionally having a oxo group, a C 2 -C 6 alkenyl group optionally having a oxo group, or A C 2 —C 6 alkynyl group which may have a oxo group;
- Substituent group A includes an octylogen atom, a hydroxyl group, an oxo group, and a C, 1 group which may have a oxo group;
- Alkoxy group, ingenuity may have a source group c 2 - c 2.
- Alkynyl group, optionally having a oxo group, C, a C 20 alkyl group, optionally having a oxo group may have a C 3 - C 2
- Arukenoiru Okishi group and old Kiso may have a group C 3 - C 2.
- W is a group —NH—, and R ′ may have a substituent selected from substituent group A; One C, 8 7 Rukanoiru groups or C,. I C, 8 al. Compound,
- W is a group NH-, and is a C 12 -C 16 alkanoyl group or a C 12 -C 7 alkenoyl group, which may have a substituent selected from substituent group A;
- R ′, R 2 , R 3 and R 4 may be the same or different and have a substituent selected from substituent group A; , 8 alkyl group, C 4 -C 18 alkenyl group, C 4 —Ci 8 alkanol group or C 4 —C, 8 alkenyl group,
- W is an oxygen atom
- R ', R 2, 13 ⁇ 4 3 and [3 ⁇ 4 4 are the same or different, may have a substituent selected from substituent group A, C, 8 Alkyl group,
- W is an oxygen atom
- R ', R 2, 13 ⁇ 4 3 and 8 4 are the same or different, may have a substituent selected from substituent group A, C l2 - C , 6 alkyl group, C, 2- €, 6 alkenyl group, C, 2 — C, 6 alkanoyl group or C, 2 — Cis alkenyl group,
- W is an oxygen atom
- R ′ and R 3 may be the same or different and may have a substituent selected from substituent group A, decanoyl group, dodecanoyl group, tetradecanoyl
- R 2 and R 4 are the same or different and are selected from Substituent group A, or a dodecenoyl group, a tetradecenoyl group or a tetradecenoyl group.
- a compound which may have a substituent which is a decyl group, a dodecyl group, a tetradecyl group, a dodecenyl group, a tetradecenyl group or a octadecenyl group;
- the substituent selected from the substituent group A is a fluorine atom, a hydroxyl group, a C, —C 20 alkoxy group, a c, 2 — c, 4 alkenyl group, a c, 2 — c, 4 alkanoyl group alkoxy group or a C, 2 - C, 4 7 compound is Rukenoiru old alkoxy group,
- the substituent selected from the substituent group A is dodecyl, tetradecyl, dodecenyl, tetradecenyl, dodecanoyl, tetradecanoyl or tetradecanoyl.
- R 5 is a halogen atom, a hydroxyl group or an unsubstituted C, 1 C 6 alkoxy group
- R 5 is a fluorine atom, a hydroxyl group or a methoxy group
- a compound in which the ⁇ ⁇ ⁇ ⁇ ⁇ position of glucose or dalcosamine on the right side is the a position.
- more preferred compounds are
- Phoswood 6 0— ⁇ 4-0—Phosphonone 3 — 0— [(R) — 3—Methoxy decyl] 1 6 — O—Methyl— 2 — O— [(Z)-1 1 year old Cutadecenyl] - ⁇ -D-glucopyranosyl ⁇ — 3—0—dodecyl-2—0 — [(R) —3-hydroxyltradecyl] -1- ⁇ , /? — D-Darcovyranoside (Compound No. 13)
- the present invention also relates to a medicament containing the above compound (I) as an active ingredient, and in particular, a prophylactic or therapeutic agent for inflammation, a prophylactic or therapeutic agent for an autoimmune disease, an immunosuppressant, a prophylactic agent for sepsis or It is a therapeutic agent or an agent for improving prognosis after coronary artery bypass graft surgery.
- a prophylactic or therapeutic agent for inflammation a prophylactic or therapeutic agent for an autoimmune disease
- an immunosuppressant a prophylactic agent for sepsis or It is a therapeutic agent or an agent for improving prognosis after coronary artery bypass graft surgery.
- the order of Q is not particularly limited.
- the base - ⁇ -AI k— may be either —0—A lk— or —AI k—O—. Good.
- the “C, 1 C 3 alkylene group” in the present invention is, for example, a linear or branched C, —C 3 alkylene group such as a methylene, ethylene, propylene, and trimethylene group. , Ethylene or a trimethylene group, and more preferably, an ethylene group.
- "C, -. C 2 Arukanoiru group” and may have a ⁇ old Kiso group C, one C 2 () Arukanoiru old alkoxy group "of the" C, -.
- C 4 - Ci 8 is Arukanoiru group, preferably good Li, C 8 - a C, 8 Arukanoiru group, even more preferably more, C,.
- One C, 8 alkanoyl group particularly preferably a Ci 2 —C, 6 alkanoyl group.
- Rc 3 —c 2 in the present invention Alkenyl group "and rc 3 — c 2 . Alkenol group rc 3 — c 2 .
- the “alkenoyl” portion is a group having 3 to 20 carbon atoms and having 1 to 3 double bonds among the c, —c 2 () alkanoyl groups described above, and is preferably the a C 4 one C u Arukenoiru groups, more favorable suitable are C 8 - a C, 8 7 Rukenoiru group, even more preferably more, C,.
- One C 18 alkenoyl group particularly preferably a C, 2 -C, 6 alkenoyl group.
- "C 3 - C 20 Arukinoiru group” and "C 3 - C 20 Arukinoi Le Sai alkoxy group” rc 3 - C 2.
- alkynyl part is C, — C 2 mentioned above.
- alkanoyl groups those having 3 to 20 carbon atoms and having 1 to 3 triple bonds, preferably C 4 -C, 8 alkynyl groups, more preferably the, C 8 - C u Arukinoiru a group, even more preferably more, C, i. —C u alkynyl group, particularly preferably C, 2 —C 16 alkynyl group.
- the “C, _C 2 () alkyl J moiety of the“ C, 1 C 2 (1 alkyl group) ”and“ C, 1 C 2fl alkoxy group ” is, for example, methyl, ethyl, propyl, isopropyl Butyl, isobutyl, s-butyl, tert-butyl, pentyl, isobentyl, 2-methylbutyl, neopentyl, 1-ethylpropyl, hexyl, isohexyl, 4-methylpentyl, 3-methylpentyl, 2-methylpentyl, 1 -Methylpentyl, 3,3-dimethylbutyl, 2,2-dimethylbutyl , ⁇ , 1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,3-dimethylbutyl, 2-ethylbutyl, heptyl
- the “C 2 —C 2 .alkenyl group” in the present invention is one of the above-mentioned C, —C 2D alkyl groups having 2 to 20 carbon atoms and having 1 to 3 double groups.
- Alkynyl 3 ⁇ 4J is the above-mentioned C, one C 2. Alkyl group having 2 to 20 carbon atoms, and having ⁇ to 3 triple bonds.
- the “halogen atom” in the present invention is a fluorine, chlorine, bromine or iodine atom, preferably a fluorine, chlorine or bromine atom, and more preferably a fluorine atom.
- the “C, 1C 6 alkoxy group” in R 5 of the present invention includes, for example, methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, S-butoxy, tert-butoxy, pentyloxy, isopopentyl 2-methylpentyl, 2-pentyl, neopentyl, 1-ethylpropyl, hexyl, isohexyl, 4-methylpentyl, 3-methylpentyl, 2-methylpentyl, 2-methylpentyl, 1-methyl Pentyl, 3,3-dimethylbutyl, 2,2-dimethylbutyl, ⁇ , ⁇ —dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, A straight-chain or branched-chain alkoxy group having 1 to 6 carbon atoms such as 2,3-dimethylbutyloxy or 2-ethylbutyloxy group; , Preferably
- C 2 - C 6 alkenyl old alkoxy group C mentioned above, among one C s alkoxy group, be of 2 to 6 carbon atoms, one double It is a group having a bond, preferably a C 2 -C 4 alkenyl group.
- the “C 2 —C 6 alkynyloxy group” in R 5 of the present invention is one having 2 to 6 carbon atoms among the above C, 1 C 6 alkoxy groups, and ⁇ triples It is a group having a bond, preferably a C 2 -C 4 alkynyloxy group.
- the "alk, alkoxy group” is the above-mentioned substituted rc, -c 20 alkoxy group substituted by one, and is preferably a (c, -c 6 alkoxy) c,-c s alkoxy group.
- “(( ⁇ — ( ⁇ . Alkoxy) C, — C 2 .alkoxy ⁇ C, —C 20 alkoxy group” is the above-mentioned r (c, —C 2Q alkoxy) c, — c 2fl .
- an alkoxy group "is exemplified by one substituted the one c 2 is an alkoxy group", preferably, ⁇ (C, - C 6 alkoxy) C, - Cs alkoxy group ⁇ C, single c s
- the oxo group is substituted with an alkyl, alkenyl, alkynyl, alkoxy, alkenyl or alkynyl group, the oxo group is
- alkyl, alkenyl, alkynyl, alkoxy, alkenyl, or alkynyl substituted with a oxo group is alkanoyl, alkenyl, alkynyl, alkanoyl, alkenoyl or alkynyloxy, respectively.
- the “substituent group A” of the present invention is preferably a fluorine atom, a hydroxyl group, C, 1 C 2 .
- alkoxy group C, 2 - C 14 alkenyl old alkoxy group, C, 2 - C M alk noisy Ruo alkoxy group and C, 2 - a group consisting of C M Arukenoiru old alkoxy group, and more preferably, dodecane Silyl group, Tetradecyl group, Dodecenyloxy group, Tetradecenyl group, Dodecanoyloxy group, Tetradecanoyloxy group, Dodecenyl group, Tetradecenyl group, and Tetradecenoyl group It is a group consisting of a decenoyl group.
- the substitution position of the substituent group A is preferably the 3-position.
- the compound of the above formula (I) can be made into a salt, and such a salt is preferably a sodium salt, a potassium salt, a magnesium salt or a calcium salt. Salts of such alkali metals or alkaline earth metals; salts of organic bases such as triethylamine salts and trimethylethylamine salts.
- the compound (I) of the present invention may absorb water, leave adsorbed water or form a hydrate when left in the air, and such salts are also included in the present invention. Is done.
- the compound of the present invention ( ⁇ may absorb some other solvent to form a solvate, and such a salt is also included in the present invention.
- the compound of the above formula (I) Has an asymmetric carbon in the molecule, and there are stereoisomers each having S-coordinate and R-coordinate, and each of them or a mixture thereof is included in the present invention. effect
- the left sugar glucose lipid A analog of the present invention exhibits an excellent macrophage activity inhibitory action, and is an anti-inflammatory agent, an anti-autoimmune disease agent, an immunosuppressant, an antiseptic agent, or an agent for improving prognosis after coronary artery bypass graft surgery.
- an anti-inflammatory agent an anti-autoimmune disease agent, an immunosuppressant, an antiseptic agent, or an agent for improving prognosis after coronary artery bypass graft surgery.
- the compound having the general formula (I) of the present invention can be produced by the following method using the known compound (II) as a starting material. ⁇
- R is a p-methoxybenzyl group.
- R 4b is a C, 1C, 7 alkyl group, a C 2 -C, 7 alkenyl group or a C 2 -C 17 alkynyl group.
- R 5a has the same meaning as R 5 except that an unprotected hydroxyl group is excluded.
- R 5b is a hydroxyl-protecting group, preferably a benzyl group or an arylcarbonyl group.
- R ⁇ R 7, RR '° , R' 1 and R '2 are the same or different, C, - C 4 alkyl group or a C 6 - C ,. Represents an aryl group.
- R 9 and R 15 are the same or different and each may have an aryl group or a substituent C 6 —C. It represents an aryl group or a C 7 —C ,, aralkyl group which may have a substituent, and preferably represents an aryl group, a phenyl group or a benzyl group.
- R ′ 3 represents an aryl xycarbonyl group.
- R 14 represents a hydrogen atom or a tri (C, —C 6 alkyl) silicon group.
- R 16 represents a C, —C 6 alkyl group.
- the step of producing the compound (I) of the present invention comprises the methods A to C.
- Method A is a method for producing an intermediate (XIVa) or (XVI I I).
- Method B uses intermediates (XXV1 I), (XXIX), (XXXI I l) s (XXXV), (XXXVI II), (XLI II), (XUX), (LI I), (LVI) , (LXX) or (LXXIV)
- Method C is a step of condensing the intermediate produced by Method A and the intermediate produced by Method B to produce the target compound (la), (lb), (I) or (lc) .
- each step will be described.
- This method is a method for producing an intermediate (XlVa) used for producing a compound (I) in which R 5 is a group other than a hydrogen atom.
- the hydroxyl group at the 3-position of the diaceton-D-glucose compound (II) is alkylated (including the case where an alkenyl group or an alkynyl group is introduced.
- alkylation is achieved by the following method (a) and acylation is achieved by the following method (b).
- This step is achieved by reacting compound (II) with an alkylating agent in an inert solvent in the presence of a base.
- solvent used examples include ethers such as dioxane and tetrahydrofuran; amides such as formamide and dimethylformamide; Halogenated hydrocarbons such as methane are exemplified, and dimethylformamide is preferred.
- alkali metal hydroxides such as sodium hydroxide and potassium hydroxide
- alkyl lithiums such as ⁇ -butyllithium and t-butyllithium
- lithium hydride sodium hydride
- Hydrogen hydride metal such as aluminum, and the like, and preferably hydrogen hydride sodium.
- alkylating agent examples include halogenated hydrocarbons and sulfonates, and preferably, bromide (R 4 Br), iodide (RI) or methanesulfonate ( R 4 OS 0 2 Me).
- the reaction temperature is usually from 0 ° C. to 100 ° C., preferably from 20 ° C. to 60 ° C.
- the reaction time varies depending on the reaction temperature, starting materials, reagents, solvent used and the like, but is usually 20 minutes to 48 hours, and preferably 2 to 24 hours.
- the target compound of this reaction is collected from the reaction mixture according to a conventional method. For example, after neutralizing the reaction mixture, concentrating, adding a water-immiscible organic solvent such as ethyl acetate, washing with water, separating the organic layer containing the target compound, drying over anhydrous magnesium sulfate, etc., and removing the solvent. Obtained by distillation.
- the obtained compound can be purified by a conventional method, for example, recrystallization, silica gel chromatography, or the like.
- This step is achieved by reacting compound (II) with an acylating agent such as a carboxylic acid or an acid chloride in an inert solvent in the presence or absence of a condensing agent and a base.
- an acylating agent such as a carboxylic acid or an acid chloride in an inert solvent in the presence or absence of a condensing agent and a base.
- solvent to be used examples include ethers such as tetrahydrofuran and dioxane; octalogenated hydrocarbons such as methylene chloride, chloroform, and carbon tetrachloride; and N-dimethylformamide.
- ethers such as tetrahydrofuran and dioxane
- octalogenated hydrocarbons such as methylene chloride, chloroform, and carbon tetrachloride
- N-dimethylformamide examples include methylene chloride.
- Condensing agents used in the reaction with carboxylic acids include 1,3-dicyclohexene.
- Examples include carboimides such as silcarbodiimide, 1,3-diisopropylcarbodiimide, and tri- [3- (dimethylamino) propyl] -3-ethylcarbodiimide hydride chloride (WSCI).
- WSCI tri- [3- (dimethylamino) propyl] -3-ethylcarbodiimide hydride chloride
- it is preferably 1,3-dicyclohexylcarbodiimide or WSCI.
- Examples of the base used in the reaction with the acid chloride include organic bases such as pyridine, dimethylaminopyridine and triethylamine, and preferred is 4-dimethylaminopyridine or triethylamine.
- acylating agent to be used a carboxylic acid represented by the formula: R z '0H, or a formula: R 4 ' CI (where R 4 'is an alkanoyl group in the definition of R 4 , And an alkynyl group or an alkynyl group).
- R 4 ' is an alkanoyl group in the definition of R 4
- R 4 ' is an alkanoyl group in the definition of R 4
- an alkynyl group or an alkynyl group When these acylating agents have a hydroxyl group or a oxo group, such groups may be protected, for example, an oxo group is protected as a ketal group.
- the reaction temperature is usually from 0 ° C. to 100 ° C., and preferably from 5 ° C. to 25 ° C. (room temperature).
- the reaction time is usually from 20 minutes to 24 hours, preferably from 5 hours to 5 hours.
- the target compound of this reaction is collected from the reaction mixture according to a conventional method.
- the reaction mixture is filtered, an organic solvent immiscible with water, such as ethyl acetate, is added.
- an organic solvent immiscible with water such as ethyl acetate
- the organic layer containing the target compound is separated, dried over anhydrous magnesium sulfate, etc., and then the solvent is distilled off. Is obtained.
- the obtained compound can be purified by a conventional method, for example, recrystallization, silica gel chromatography, or the like.
- This step is a step of obtaining a compound (IV) by heating the compound (III) in an aryl alcohol solvent in the presence of hydrochloric acid gas.
- the reaction temperature is usually from room temperature to the reflux temperature of the solvent, and is preferably room temperature to 80 ° C.
- the reaction time is generally 20 minutes to 24 hours, preferably 30 minutes to 5 hours. Time.
- This step is a step of obtaining a compound (V) by bridging isopropylidene to the 4- and 6-position hydroxyl groups of the compound (IV). This step is achieved by reacting compound (IV) with 2,2-dimethyloxypropane in an inert solvent in the presence of an acid catalyst.
- solvents to be used include amides such as dimethylformamide.
- Examples of the acid catalyst used include P-toluenesulfonic acid and camphorsulfonic acid.
- the reaction temperature is usually from room temperature to 50 ° C.
- the reaction time is usually 20 minutes to 24 hours.
- the target compound (V) of the reaction is collected from the reaction mixture according to a conventional method.
- the reaction mixture is concentrated, a water-immiscible organic solvent such as ethyl acetate is added, and after washing with water, the organic layer containing the target compound is separated, dried over anhydrous magnesium sulfate or the like, and then the solvent is distilled off. It can be obtained by:
- the obtained compound can be purified by a conventional method, for example, recrystallization, silica gel chromatography, or the like.
- the double bond of the aryl group of compound (V) is transferred to an enol ether type to produce compound (VI).
- This step is achieved by reacting compound (V) with a base or an iridium complex in an inert solvent.
- solvent to be used examples include ethers such as e.g., tetrahydrofuran and dioxane; and sulfoxides such as dimethyl sulfoxide.
- ethers such as e.g., tetrahydrofuran and dioxane
- sulfoxides such as dimethyl sulfoxide.
- dimethyl sulfoxide is preferably used.
- an iridium complex it is preferably tetrahydrofuran.
- potassium tert-butoxide sodium Metal alkoxides such as sodium hydroxide and sodium hydroxide are preferred, and potassium tert-butoxide is preferred.
- iridium complex for example, (1,5-cyclobutadiene octadiene) bis (methyldiphenyl wood sphine) iridium (I) hexaflurophosphophosphate can be mentioned.
- the reaction temperature is usually from room temperature to the reflux temperature of the solvent when a base is used, and is usually from 0 ° C. to 80 ° C. when the iridium complex is used, and is preferably room temperature.
- the reaction time is generally 1 hour to 24 hours, preferably 16 hours.
- the target compound (VI) of this reaction is collected from the reaction mixture according to a conventional method.
- the reaction mixture is concentrated, a water-immiscible organic solvent such as ethyl acetate is added, and after washing with water, the organic layer containing the target compound is separated, dried over anhydrous magnesium sulfate or the like, and then the solvent is distilled off. It can be obtained by:
- the obtained compound can be purified by a conventional method, for example, recrystallization, silica gel chromatography, or the like.
- This step is a step of alkylating or acylating the hydroxyl group at the 2-position of compound (VI) to obtain compound (VII), which is achieved by reacting under the same conditions as in step Aa1.
- This step is a step for producing a compound (VIII) by deprotecting the isopropylidyl bridged to the 4- and 6-position hydroxyl groups of the compound (VII). This step is achieved by reacting the compound (VII) with an acid catalyst or NBS in 80% aqueous acetic acid or an alcohol solvent.
- Examples of the solvent used include alcohols such as methanol and ethanol.
- Examples of the acid catalyst used include organic acids such as P-toluenesulfonic acid and camphorsulfonic acid; and inorganic acids such as hydrochloric acid and sulfuric acid.
- the reaction temperature is usually from room temperature to 100 ° C. in an aqueous acetic acid solvent, and is usually from 0 ° C. to 50 ° C. in an alcohol, and preferably room temperature.
- the reaction time is generally 6 minutes to 24 hours, preferably 6 minutes to 3 hours.
- the target compound (VIII) of this reaction is collected from the reaction mixture according to a conventional method.
- the reaction mixture is concentrated, a water-immiscible organic solvent such as ethyl acetate is added, washed with water, the organic layer containing the target compound is separated, dried over anhydrous magnesium sulfate, and the solvent is distilled off. Obtained by leaving.
- the obtained compound can be purified by a conventional method, for example, recrystallization, silica gel chromatography, or the like.
- This step is a step of producing a compound (IX) by protecting the primary hydroxyl group of the diol of the compound (VIII) with a silyl group. This step is achieved by reacting the compound (VIII) with a silylating agent in an inert solvent in the presence of a base.
- solvent to be used examples include ethers such as tetrahydrofuran and dioxane; octalogenated hydrocarbons such as methylene chloride, chloroform and carbon tetrachloride. Or tetrahydrofuran.
- Examples of the base used include organic bases such as pyridine, dimethylaminopyridine and triethylamine.
- silylating agent to be used examples include octogenated trialkylsilyl groups such as tert-butyldimethylsilyl chloride.
- the reaction temperature is usually 0 ° C. to 80 ° C., preferably room temperature.
- the reaction time is usually from 6 minutes to 24 hours.
- the target compound () of this reaction is collected from the reaction mixture according to a conventional method. For example, concentrate the reaction mixture and do not mix with water such as ethyl acetate It is obtained by adding an organic solvent, washing with water, separating an organic layer containing the target compound, drying over anhydrous magnesium sulfate or the like, and distilling off the solvent.
- water such as ethyl acetate
- the obtained compound can be purified by a conventional method, for example, recrystallization, silica gel chromatography, or the like.
- This step is a step of producing the compound (X) by converting the compound () into phosphite and further oxidizing the compound.
- compound (IX) is reacted with diisopropylphosphoramidite in the presence of 1H-tetratolazole, which is a weak acid, in an inert solvent, and further reacted with an oxidizing agent in an inert solvent. This is achieved by:
- solvent used examples include ethers such as tetrahydrofuran and dioxane; and halogenated hydrocarbons such as methylene chloride, chloroform, carbon tetrachloride, dichloroethane and chlorobenzene.
- the oxidizing agents used include, for example, peroxides such as hydrogen peroxide, tn-chloroperbenzoic acid, and xyloxone.
- the reaction temperature is generally 0 ° C. to 100 ° C., preferably room temperature.
- the reaction time is usually from 6 minutes to 24 hours.
- the target compound (X) of this reaction is collected from the reaction mixture according to a conventional method.
- the reaction mixture is concentrated, a water-immiscible organic solvent such as ethyl acetate is added, and after washing with water, the organic layer containing the target compound is separated, dried over anhydrous magnesium sulfate or the like, and then the solvent is distilled off. It can be obtained by:
- the obtained compound can be purified, if necessary, by a conventional method, for example, recrystallization or silica gel chromatography.
- the silyl protecting group of compound (X) is deprotected to produce compound (XI) which is a primary alcohol.
- This step is achieved by reacting compound (X) with an acid catalyst in an inert solvent.
- the solvent used include ethers such as tetrahydrofuran and dioxane; ditriles such as acetate ditril; methylene chloride, chloroform, carbon tetrachloride, dichloroethane, and chloroform.
- Octalogenated hydrocarbons such as benzene.
- Examples of the acid catalyst used include inorganic acids such as hydrochloric acid and hydrofluoric acid; and organic acids such as P-toluenesulfonic acid.
- the reaction temperature is usually 20 ° C. to 50 ° C., and preferably room temperature.
- the reaction time is usually 6 minutes to 2 hours, preferably 15 minutes.
- the target compound (XI) of the reaction is collected from the reaction mixture according to a conventional method.
- the reaction mixture is concentrated, a water-immiscible organic solvent such as ethyl acetate is added, and after washing with water, the organic layer containing the target compound is separated, dried over anhydrous magnesium sulfate or the like, and then the solvent is distilled off. It can be obtained by: ,
- the obtained compound can be purified by a conventional method, for example, recrystallization, silica gel chromatography, or the like.
- compound 6-position compound hydroxyl group is converted to (XI) (XI I) be Rue ⁇ to produce, may be R 5a is have a talent Kiso group C, one C 6 alkoxy C 2 -C 6 alkenyl group which may have oxo group or C 2 -C 6 alkynyl group which may have oxo group
- R 5a is a talent Kiso group C, one C 6 alkoxy C 2 -C 6 alkenyl group which may have oxo group or C 2 -C 6 alkynyl group which may have oxo group
- R 5a has a C, -C 6 alkoxy group which may have a oxo group, a C 2 _C s alkenyl which may have a oxo group, or an oxo group which may have a oxo group; C 2 — C s If it is an alkynyl group
- This step is achieved by reacting the compound (XI) with an alkylating agent or the like in an inert solvent in the presence of a base or silver oxide (II) (AgO).
- the solvent used does not hinder the reaction and dissolves starting materials to some extent
- a hydrocarbon for example, aliphatic hydrocarbons such as hexane, heptane, and lignin; aromatic hydrocarbons such as benzene, toluene, and xylene; methylene chloride, chloroform, Halogenated hydrocarbons such as carbon tetrachloride, dichloroethane, and chlorobenzene; esters such as ethyl acetate, propyl acetate, and getyl carbonate; ethers such as getyl ether, diisopropyl ether, tetrahydrofuran, and dioxane Classes; nitritols such as acetate nitrile and isopyronitrile; amides such as formamide, N, N-dimethylformamide, and M-dimethylacetamide Preferably, they are ethers.
- Examples of the base to be used include alkali metal carbonates such as sodium carbonate and carbonated carbonate; small alkali metal carbonates such as sodium carbonate and potassium hydrogencarbonate; Al-metal hydrides such as lithium and hydrogenated lithium; N-methylmorpholine, triethylamine, tributylamine, diisopropylethylamine, dicyclohexylamine, M-methylbiperidine, pyridine, picoline , 4- (M-dimethylamino) pyridine, 2,6-di (t-butyl) -1-methylpyridine, fJ, N-dimethylaniline, N, N-Jetylaniline, 1,5-diazabicyclo [4.3 [0] Noner 5-ene (DBN), 1,4-Diazavicik mouth [2.2.2] Octane (DABC 0), 1,8-Diazabicyclo [5.4.0] Pindecar 7-ene ( Organic bases such as DBU) It can be mentioned. Preferably, they
- R 5a 'Z (wherein, R 5a' represents the same meaning as other the R 5a except halogen atom, Z is an iodine atom, a bromine atom, EnsoHara child, A paratoluenesulfonyl group or a methanesulfonyl group.)
- the reaction temperature is usually from 0 ° C. to 100 ° C., and preferably from 0 ° C. to 30 ° C.
- the reaction time is generally about 0 minute to 24 hours, preferably 1 to about 8 hours.
- This step is achieved by reacting the compound (XI) with trimethyloxoniumtetrachloride in an inert solvent in the presence of a base.
- solvent to be used examples include ethers such as ether, dioxane and tetrahydrofuran; octogenated hydrocarbons such as methylene chloride, chloroform and carbon tetrachloride; formamide, N, N-dimethyl Amides such as formamide and ⁇ , ⁇ -dimethylacetamide can be mentioned, and methylene chloride is preferred.
- 2,6-ditert-butyl-4-methylpyridine can be exemplified.
- the reaction temperature is usually carried out in one 5 0 e C to 1 0 0 ° C, preferably a 0 ° C to 3 0 ° C.
- the reaction time is generally 1 to 24 hours, preferably 2 to 5 hours.
- the target compound (XII) of this reaction is collected from the reaction mixture according to a conventional method. For example, after neutralizing the reaction mixture, concentrating it, adding a water-immiscible organic solvent such as ethyl acetate, washing with water, separating the organic layer containing the target compound, drying over anhydrous magnesium sulfate, etc., and removing the solvent. Obtained by distillation.
- the obtained compound can be further purified, if necessary, by a conventional method, for example, recrystallization, silica gel, chromatography or the like.
- This step is achieved by reacting the compound (XI) with a fluorinating agent in an inert solvent.
- solvent to be used examples include octogenated hydrocarbons such as methylene chloride and full-length trichloromethane; ethers such as ether and 2-dimethyloxetane. And methylene chloride.
- fluorinating agent examples include, for example, One example is the “Digital Lido” (DAST).
- the reaction is usually carried out at a temperature of from 178 ° C to 25 ° C, preferably from 0 ° C to 2 ° C.
- the reaction time is generally ⁇ to 18 hours, but preferably ⁇ to 5 hours.
- R 5a is chlorine or bromine
- This step is achieved by reacting compound (XI) with phosphorus trichloride, phosphorus tribromide, phosphoryl trichloride, phosphoryl tribromide, thionyl chloride or thionyl bromide in an inert solvent. .
- the solvent used is preferably octogenated hydrocarbons such as methylene chloride, chloroform, and carbon tetrachloride.
- the reaction temperature is usually from ⁇ 50 ° C. to 50 ° C., preferably from 10 ° C. to 30 ° C.
- the reaction time is generally 1 to 18 hours, preferably 1 to 5 hours.
- This step is accomplished by reacting compound (XI) with iodine and triphenylphosphine in an inert solvent.
- the solvent used is not particularly limited as long as it does not inhibit the reaction and dissolves the starting material to a certain degree or more.
- aliphatic hydrocarbons such as hexane, heptane, and lignin
- benzene Aromatic hydrocarbons such as methylene chloride, toluene and xylene
- Halogenated hydrocarbons such as methylene chloride, chloroform, carbon tetrachloride, dichloroethane, and chlorobenzene
- esters such as ethyl acetate, propyl acetate and getyl carbonate Ethers such as getyl ether, disopropyl ether, tetrahydrofuran and dioxane
- alcohols such as methanol and ethanol
- formamide, N, N-dimethylformamide, N, N Amides such as dimethylacetamide, but preferably ethers.
- the reaction temperature is usually from ⁇ 50 to 100 ° C., preferably from 0 ° C. to 3 ° C. 0 ° C.
- the reaction time is generally 1 to 18 hours, preferably 1 to 5 hours.
- the target compound (XII) of this reaction is collected from the reaction mixture according to a conventional method. For example, after neutralizing the reaction mixture, concentrating it, adding a water-immiscible organic solvent such as ethyl acetate, washing with water, separating the organic layer containing the target compound, drying over anhydrous magnesium sulfate, etc., and removing the solvent. Obtained by distillation.
- the obtained compound can be purified by a conventional method, for example, recrystallization, silica gel chromatography, or the like.
- This step is a step of producing a compound (XMI) by deprotecting the protecting group at the 1-position hydroxyl group of the compound (XII), and is achieved by reacting the compound (XMI) with an acid catalyst in an inert solvent.
- solvent used examples include, for example, halogenated hydrocarbons such as methylene chloride, chloroform, carbon tetrachloride, dichloro: t-tan, cyclobenzene, and dichlorobenzene; acetate nitrile, isopyronitrile Nitriles such as '
- Examples of the acid catalyst used include a 48% aqueous hydrofluoric acid solution.
- the reaction temperature is generally 0 ° C. to 100 ° C., preferably room temperature.
- the reaction time is generally 6 minutes to 24 hours, preferably about 6 hours.
- This step is a process for producing a trichloroacetimidate compound (Xl Va), in which trichloroacetatetritril is allowed to act on the 1-hydroxyl group of compound (XIII) in an inert solvent in the presence of a base. This is achieved by:
- Solvents used are, for example, octogenated hydrocarbons such as methylene chloride, black form, carbon tetrachloride; ethers such as ether, dioxane, tetrahydrofuran; esters such as ethyl acetate. ; Like Acetonitrile Nitriles are preferred, and halogenated hydrocarbons (methylene chloride) are preferred.
- octogenated hydrocarbons such as methylene chloride, black form, carbon tetrachloride
- ethers such as ether, dioxane, tetrahydrofuran
- esters such as ethyl acetate.
- Acetonitrile Nitriles are preferred, and halogenated hydrocarbons (methylene chloride) are preferred.
- Examples of the base used include organic bases such as 1,8-diazabicyclo [5,4,0] -7-pandecene (DBU); and inorganic bases such as sodium hydride, potassium carbonate, and cesium carbonate.
- DBU 1,8-diazabicyclo [5,4,0] -7-pandecene
- inorganic bases such as sodium hydride, potassium carbonate, and cesium carbonate.
- the DBU statement is cesium carbonate.
- the reaction temperature is usually from 25 ° C to 50 ° C, preferably from 0 ° C to 25 ° C.
- the reaction time is usually from 10 minutes to 24 hours, preferably from 30 minutes to 2 hours.
- the target compound (XlVa) of this reaction is collected from the reaction mixture according to a conventional method. For example, after neutralizing the reaction mixture, concentrating, adding a water-immiscible organic solvent such as ethyl acetate, washing with water, separating the organic layer containing the target compound, drying over anhydrous magnesium sulfate, etc., and removing the solvent. Obtained by distillation.
- a water-immiscible organic solvent such as ethyl acetate
- This method is a method for producing an intermediate (XVI II) used for producing a compound (I) wherein R 5 is a protected hydroxyl group (Step Ab 1)
- This step is a step for producing a compound (XV) in which the 6-position hydroxyl group of the compound (VIII) is selectively protected, if desired.
- R 3 , R 4 and R 5b When an unsaturated bond is present in R 3 , R 4 and R 5b , an aryl group or an aryloxycarbonyl group which can be removed without using a reduction reaction is used. If there is no unsaturated bond in R 3 , R 4 and R 5b , the protection reaction may be performed immediately.
- This reaction is achieved by reacting a protecting agent in an inert solvent in the presence of a base.
- Solvents used include, for example, methylene chloride, chloroform, tetrasalt Halogenated hydrocarbons such as fluorinated carbon; ethers such as ether, dioxane and tetrahydrofuran; and esters such as ethyl acetate.
- Methylene chloride is preferred.
- Examples of the base used for example, pyridine, dimethyl ⁇ amino pyridine, Bok Riechiruami 1 down, N, N-but organic bases such as dimethyl ⁇ diphosphoric the like, preferably a pyridine.
- the protecting agent to be used may be any one which can recover the hydroxyl group at the 6-position in a good yield by performing the deprotection treatment.
- the protecting agent may be an alkyloxycarbonylcarbonyl such as tert-butoxycarbonyl chloride.
- alkenyl-based carbonyl halides such as aralkyl-based carbonyl carbonates and aryl-based carbonyl-based carbonyl carbonates, but unsaturated in R 3 , R 4 and R 5b.
- it is preferably benzyloxycarbonyl chloride, and when an unsaturated bond is present at R 3 , R 4 and R 5b , it is preferably aryloxycarbonyl chloride.
- the reaction temperature is usually from 150 ° C to 50 ° C, preferably from 0 ° C to 30 ° C.
- the reaction time is usually from 10 minutes to 24 hours, preferably from 30 minutes to 5 hours.
- the target compound (XV) of this reaction is collected from the reaction mixture according to a conventional method. For example, after neutralizing the reaction mixture, concentrating, adding a water-immiscible organic solvent such as ethyl acetate, washing with water, separating the organic layer containing the target compound, drying with anhydrous magnesium sulfate, etc. Is obtained by distillation.
- a water-immiscible organic solvent such as ethyl acetate
- the obtained compound can be purified by a conventional method, for example, recrystallization, silica gel chromatography, or the like.
- This step is a step of producing compound (XVI) by converting compound (XV) into wood sulfide and further oxidizing it, and is achieved by reacting under the same conditions as in step Aa8. Is done. (Step A b 3)
- step (XVI) the protecting group for the hydroxyl group of compound (XVI) is deprotected to produce compound (XVI I), which is reacted under the same conditions as in step Aa-1. Achieved.
- This step is a step of producing a trichloroacetimidate (XVIII), and is achieved by reacting under the same conditions as in the step Aa12.
- This method is a method for producing an intermediate (XXVI I) used for producing a compound (I) in which W is an NH group.
- This step is a step of producing a compound (XX) in which the 3-position hydroxyl group of the compound (X) is alkylated or acylated, and is achieved by reacting under the same conditions as in the step Aa1. You.
- This step is a step of deprotecting the 2-position of compound (XX) to produce compound (XXI).
- This step is a step of deprotecting 2-position triacetate roacetamide of compound (XIX) in an inert solvent under alkaline conditions.
- Examples of the solvent to be used include alcohols such as methanol and ethanol; ethers such as getyl ether and tetrahydrofuran; and nitriles such as acetobutritol.
- alcohols ethanol
- Examples of the alkali used include sodium hydrogencarbonate and alkali metal hydrogencarbonates such as potassium hydrogencarbonate; sodium hydroxide, alkali metal hydroxide such as sodium hydroxide and sodium hydroxide; sodium Examples thereof include alkali metal alkoxides such as methoxide and sodium ethoxide, and are preferably alkali metal hydroxides.
- the reaction temperature is usually from 0 ° C to 100 ° C, but is preferably from 25 ° C to reflux temperature.
- the reaction time is generally 30 minutes to 24 hours, preferably 1 to 16 hours.
- This step is a step of producing a compound (XXII) by amidating the amino group of the compound (XXI) with a carboxylic acid, an acid halide thereof or an acid anhydride thereof.
- Examples of the condensing agent used in the condensation reaction with a carboxylic acid include carpoimides such as DCC and WSCI.
- Bases used in the amide formation reaction with acid halides include, for example, alkali metal carbonates such as sodium carbonate, lithium carbonate, lithium carbonate; sodium hydrogen carbonate, lithium hydrogen carbonate, carbonate Alkali metal bicarbonates such as lithium hydrogen; and organic bases such as pyridine, dimethylaminopyridine and triethylamine.
- Solvents used in the condensation reaction include, for example, halogenated hydrocarbons such as methylene chloride, chloroform, carbon tetrachloride, dichloroethane, chlorobenzene, and dichlorobenzene; getyl ether, diisopropyl ether, tetrahydrofuran, Ethers such as dioxane, dimethyloxetane, and diethylene glycol dimethyl ether; ditolyls such as acetonitrile and isobutyronitrile; formamide, N, N-dimethylformamide, N, N-dimethylacetamide; Amides such as N-methyl-2-pyrrolidone, N-methylpyrrolidinone, hexamethyl phosphorotriamide; water and their mixtures Solvents.
- halogenated hydrocarbons such as methylene chloride, chloroform, carbon tetrachloride, dichloroethane, chlorobenzene, and dichloro
- the reaction time is usually from 0 ° C. to 100 ° C.
- the reaction temperature in the case of the condensation reaction is usually from 6 minutes to 24 hours.
- This step is a step of deprotecting the isopropylidyl bridged to the 4- and 6-position hydroxyl groups of the compound (II) to produce the compound (XXIII) under the same conditions as in the step Aa6. It is achieved by reacting. (Step B a 5)
- This step is a step of producing the compound (XXIV) by protecting the primary hydroxyl group of the diol of the compound (XXIII) with a silyl group, and can be achieved by carrying out the same reaction as in the step Aa7. (Step B a 6)
- Step B a 7 the double bond of the aryl group of the compound (XXIV) is transferred to the enol ether form to produce the compound (XXV), which is achieved by reacting under the same conditions as in the step Aa4. Is done. , (Step B a 7)
- This step is a step of protecting the secondary hydroxyl group of compound (XXV) with an aryloxycarbonyl group to produce compound (XXVI). This step is achieved by reacting compound (XXV) with a carbonate agent in an inert solvent in the presence of a base, and further with an alcohol.
- solvent to be used examples include ethers such as tetrahydrofuran and dioxane; aromatic hydrocarbons such as benzene, toluene and xylene; methylene chloride, chloroform, carbon tetrachloride, dichloroethane, and chloroform.
- ethers such as tetrahydrofuran and dioxane
- aromatic hydrocarbons such as benzene, toluene and xylene
- methylene chloride, chloroform, carbon tetrachloride, dichloroethane, and chloroform halogenated hydrocarbons such as benzene are mentioned.
- Examples of the base used include pyridine, dimethylaminopyridine, Organic bases such as liethylamine are exemplified.
- Triphosgene can be used as a carbonating agent.
- Alcohols used include alcohols.
- the reaction temperature is usually from 120 ° C. to 50 ° C., preferably 0 ° C.
- the reaction time is usually 10 minutes to 1 hour after the addition of the carbonate agent and before the addition of the alcohol, and preferably 10 minutes, preferably 1 minute after the addition of the alcohol. 0 minute to 1 hour, preferably 1 hour.
- the target compound (XXVI) of this reaction is collected from the reaction mixture according to a conventional method.
- the reaction mixture is concentrated, a water-immiscible organic solvent such as ethyl acetate is added, washed with water, the organic layer containing the target compound is separated, dried over anhydrous magnesium sulfate, and the solvent is distilled off. Obtained by leaving.
- the obtained compound can be purified by a conventional method, for example, recrystallization, silica gel chromatography or the like. (Step B a 8)
- This step is a step of producing a compound (XXVI I) by deprotecting the protecting group at the 1-position hydroxyl group of the compound (XXVI), and by reacting under the same conditions as in the step Aa11. Achieved. (2-2) b method
- This method is a method for producing an intermediate (XXXI I I) used for producing a compound (I) wherein W is an oxygen atom.
- step Aa9 the silyl protecting group of compound (XXVI II) is deprotected, and the enol ether at the anomeric position is simultaneously deprotected to produce compound (XXIX) which is a primary alcohol.
- This step is achieved by making the reaction conditions in step Aa9 stricter, for example, by lengthening the reaction time.
- the reaction time is usually 4 hours to 24 hours, preferably 10 hours to 16 hours. Between.
- the target compound (XXIX) of this reaction is collected from the reaction mixture according to a conventional method.
- the reaction mixture is concentrated, a water-immiscible organic solvent such as ethyl acetate is added, washed with water, the organic layer containing the target compound is separated, dried over anhydrous magnesium sulfate, and the solvent is distilled off. Obtained by leaving.
- the obtained compound can be purified by a conventional method, for example, recrystallization, silica gel chromatography or the like.
- This method is a method for producing an intermediate (XXX IX) used for producing a compound (I) in which W is an oxygen atom and Q is a group represented by —0 CH 2 CH 20 —.
- This step is a step of producing compound (XXXI) by oxidatively cleaving the aryl double bond of compound (XXX) to form an aldehyde and then reducing the aldehyde.
- This step is achieved by reacting compound (XXX) with an oxidizing agent in an inert solvent, and further reacting the compound (XXX) with a reducing agent in an inert solvent.
- Examples of the solvent used include a mixed solvent of ether and water such as tetrahydrofuran and dioxane in the oxidation, and an alcohol such as methanol and ethanol in the reduction. can give.
- Examples of the oxidizing agent used include a combination of osmium tetroxide and sodium periodate.
- Examples of the reducing agent to be used include metal hydrides such as lithium aluminum hydride and sodium borohydride, and preferably sodium borohydride.
- the reaction temperature is usually 0 ° C. to 50 ° C., and preferably room temperature.
- the reaction time is usually from 6 minutes to 24 hours.
- the target compound (XXXI) of this reaction is collected from the reaction mixture according to a conventional method. For example, concentrate the reaction mixture and mix with water, such as ethyl acetate. After adding an organic solvent and washing with water, the organic layer containing the target compound is separated, dried over anhydrous magnesium sulfate or the like, and the solvent is distilled off.
- the obtained compound can be purified by a conventional method, for example, recrystallization, silica gel chromatography, or the like.
- step (XXXI) is converted to phosphite and then oxidized to produce compound (XXXI I).
- the reaction is carried out under the same conditions as in step Aa8. Achieved.
- This step is a step of producing a compound (XXXI II) by deprotecting the isopropylidene bridged to the 4- and 6-position hydroxyl groups of the compound (XXXII) under the same conditions as in step Aa6. This is achieved by reacting.
- This method is a method for producing a compound (XXXV) in which W is an oxygen atom and the hydroxyl groups at the 2- and 3-positions are protected by the same protecting group.
- This step is a step of alkylating or acylating two hydroxyl groups of the known compound (XXXIV) to obtain the compound (XXXV), and is achieved by reacting under the same conditions as in the step Aa1. . (2 — 5) e-method
- This method is a method for producing an intermediate (XXXVM 1) used for producing a compound (I) in which W is an oxygen atom and Q is a group represented by —0CH 2 CH 2 —.
- solvent to be used examples include halogenated hydrocarbons such as methylene chloride and chloroform; ethers such as tetrahydrofuran; and aromatic hydrocarbons such as benzene.
- the reaction temperature is usually from 0 ° C to the reflux heating temperature of the solvent, and preferably room temperature.
- the reaction time is usually from 6 minutes to 16 hours, and preferably from 1 hour to 3 hours.
- the target compound (XXXVI) of the reaction is collected from the reaction mixture according to a conventional method.
- the reaction mixture is neutralized, concentrated, and an organic solvent immiscible with water, such as ethyl acetate, is added.
- an organic layer containing the target compound is separated, dried over anhydrous magnesium sulfate, and the like. Obtained by distillation.
- the obtained compound (XXXVI) can be purified, if necessary, by a conventional method, for example, recrystallization, silica gel chromatography, or the like.
- This step is a step of reacting the bromine atom of the compound (XXXVI) with triallyl phosphite to produce diaryl phosphite (XXXVI I), which is usually carried out without solvent.
- the reaction temperature is usually from 150 ° C to 200 ° C. (Step Be 3)
- This step is a step for producing a diol (XXXVI II) by deprotecting the hydroxyl-protecting groups at the 4- and 6-positions of the compound (XXXVI I), and by reacting with an acid in an inert solvent. Achieved.
- Examples of the solvent used include alcohols such as methanol and ethanol; acetic acid aqueous solution (eg, 80% acetic acid aqueous solution).
- Examples of the acid used include organic acids such as acetic acid and P-toluenesulfonic acid; and inorganic acids such as hydrogen chloride.
- the reaction temperature is usually 50 ° C to 80 ° C.
- the reaction time is usually 1 hour to 6 hours.
- This method is a method for producing an intermediate (XU II) used for producing a compound (I) in which W is an oxygen atom and Q is a group represented by —CH 2 CH 20 —.
- This step is a step of obtaining a compound (XI ⁇ ) by alkylating or acylating the 2- and 3-position hydroxyl groups of the compound (XXXIX), and reacting under conditions similar to those in Step Aa5. Is achieved by
- This step is a step of producing the compound (XU) by oxidatively cleaving the aryl double bond of the compound (XL) to form an aldehyde and then reducing the aldehyde.
- the reaction is carried out under the same conditions as in the step Bc B. This is achieved by:
- step (XLI) is converted to phosphite and further oxidized to produce compound '(XLI I), which is reacted under the same conditions as in step Aa8. Achieved.
- the compound (XLI I1) is produced by deprotecting the isopropylidyl bridged to the 4- and 6-position hydroxyl groups of the compound (XUI), and is the same as the step Aa6. It is achieved by reacting under conditions. (2 — 7) g method.
- This method is a method for producing an intermediate (XL IX) used for producing a compound (I) in which W is an oxygen atom and Q is a group represented by —CH 20 —. (Process B g ⁇ )
- step Aa3 the four benzyl groups of the known compound (XL IV) are removed, and isopropylidene is further bridged on the 4- and 6-position hydroxyl groups to obtain the compound (XLV). Is achieved by a normal hydrogenation reaction, and the step of bridging isopropylidene is achieved by reacting under the same conditions as in step Aa3.
- Examples of the solvent to be used include halogenated hydrocarbons such as methylene chloride, chloroform, carbon tetrachloride; ditolyls such as acetate ditolyl; water; and a mixed solvent thereof.
- halogenated hydrocarbons such as methylene chloride, chloroform, carbon tetrachloride
- ditolyls such as acetate ditolyl
- water and a mixed solvent thereof.
- Preferred is a mixed solvent of carbon tetrachloride, acetate nitrile and water.
- the reaction temperature is usually 0 ° C to 100 ° C, preferably 40 ° C to 80 ° C.
- the reaction time is usually from 2 hours to 20 hours, preferably from 0 hours to 5 hours.
- the esterification step can be achieved by a conventional method. That is, for example, in the case of methyl esterification, it can be achieved by reacting a carboxylic acid compound with diazomethane or trimethylsilyldiazomethane in an inert solvent.
- the solvent used include ethers such as ether and tetrahydrofuran.
- the reaction temperature is usually from 0 ° C to room temperature.
- This step is a step of obtaining a compound (XLV I I) by reducing the ester group of the compound (XLV I). This step is achieved by reacting with a reducing agent in an inert solvent.
- solvent used examples include alcohols such as methanol and ethanol; and ethers such as dimethyl ether and tetrahydrofuran.
- Examples of the reducing agent to be used include metal hydrides such as lithium aluminum hydride; aluminum and sodium borohydride, and lithium aluminum hydride is preferable.
- the reaction temperature is usually 0 ° C. to 50 ° C., and preferably room temperature.
- the reaction time is usually from 6 minutes to 24 hours.
- the target compound (XLV II) of this reaction is collected from the reaction mixture according to a conventional method.
- the reaction mixture is concentrated, and a water-immiscible organic solvent such as ethyl acetate is added.
- a water-immiscible organic solvent such as ethyl acetate is added.
- the organic layer containing the target compound is separated, dried over anhydrous magnesium sulfate, etc., and then the solvent is distilled off. It is obtained by doing.
- the obtained compound can be purified by a conventional method, for example, recrystallization, silica gel chromatography, or the like.
- step (XLV II) is converted into phosphite, which is further oxidized.
- step (XLVI II) is achieved by reacting under the same conditions as in step Aa8.
- step Aa6 isopropylidene bridged to the 4- and 6-position hydroxyl groups of compound (XLVIII) is deprotected to produce compound (XUX), and the reaction is carried out under the same conditions as in step Aa6. This is achieved by
- This method is a method for producing an intermediate (UI) used for producing a compound (I) in which W is an oxygen atom and Q is a group represented by —0 (CH 2 ) 30 —.
- the aryl double bond of the compound (XXX) is oxidatively cleaved to give an aldehyde, which is then reduced to produce the compound (I).
- the reaction is carried out under the same conditions as in the step Bc B. This is achieved by
- This step is a step of producing compound (LI) by converting compound) into phosphite and further oxidizing the compound, and is achieved by reacting under the same conditions as in step Aa8.
- step Aa6 isopropylidene bridged to the 4- and 6-position hydroxyl groups of compound (U) is deprotected to produce compound (LII).
- the reaction is carried out under the same conditions as in step Aa6. This is achieved by
- W is an oxygen atom
- Q is a group represented by —OCH 2 CH 20 —.
- This step is a step of producing the compound (L1V) by oxidizing and breaking the aryl double bond of the compound (LI II) to produce an aldehyde, and then reducing the aldehyde under the same conditions as in Step Bc. It is achieved by reacting.
- step (LIV) is converted to phosphite and then oxidized to produce compound (LV), which is achieved by reacting under the same conditions as in step Aa8. Is done.
- This step is a step of producing the compound (LVI) by protecting the secondary hydroxyl group of the compound (LV) with an acyl group.
- the reaction is carried out under the same conditions as in the step B a ⁇ (b). This is achieved by deprotecting the isopropylidene group under acidic conditions under the same conditions as in step Aa6.
- This method is a method for producing an intermediate (LXX) used for producing a compound (I) in which W is an oxygen atom.
- This step is a step of obtaining a compound (LXV) by alkylating or acylating the hydroxyl group at the 2-position of the compound (LXIV), and is achieved by reacting under the same conditions as in the step Aa1.
- the double bond of the aryl group of the compound (LXVI) is transferred to the enol ether form to produce the compound (LXVI I).
- the reaction is carried out under the same conditions as in the step Aa4. Achieved.
- This step is a step of producing the compound (LXVI II) by protecting the primary hydroxyl group of the diol of the compound (LXVI I) with a silyl group, and is accomplished by reacting under the same conditions as in step Aa7. You.
- step 3 the secondary hydroxyl group of compound (LXVI II) is protected with an aryloxycarbonyl group to produce compound (LXIX), and the reaction is carried out under the same conditions as in step Ba7. Is achieved.
- This step is a step of producing a compound (LXX) by deprotecting the protecting group for the hydroxyl group at the 1-position of the compound (LXIX), and is achieved by reacting under the same conditions as in the step Aa11. Is done.
- This method is a method for producing an intermediate (LXXIV) used for producing a compound (I) in which W is an NH group.
- Step B k 2 the aryl double bond of compound (LXXI) is oxidatively cleaved to an aldehyde. Thereafter, the compound (LXXI I) is produced by reducing ⁇ and further deprotecting the 2-position, which is achieved by reacting under the same conditions as in the steps Bc1 and Ba2. Is done. (Step B k 2)
- Step B k 3 the compound (LXXII) is converted to phosphite, oxidized, and the amino group is amidated to produce the compound (LXXII). It is achieved by carrying out the reaction under the same conditions as in the Ba 3 step. (Step B k 3),
- This step is a step of producing a compound (LXXIV) by deprotecting the isopropylidene bridged to the 4- and 6-position hydroxyl groups of the compound (LXXI II). This is achieved by (3) Method C
- This method is a method for producing the present compound () wherein Q is an oxygen atom. (Step C a 1)
- compound (XXVI 1), (XXIX) or (LXX) is subjected to a glycosylation reaction with compound (XIV) to produce compound (LVI I).
- This step is performed in an inert solvent in the presence of a catalyst.
- solvent to be used examples include octahedral hydrocarbons such as methylene chloride and chloroform.
- Examples of the catalyst to be used include Lewis acids such as tin tetrachloride, triflurophilic roboron Z etherate, aluminum chloride, ferric chloride, trimethylsilyl triflate, and silver triflate; and molecular sieves 4A.
- Lewis acids such as tin tetrachloride, triflurophilic roboron Z etherate, aluminum chloride, ferric chloride, trimethylsilyl triflate, and silver triflate
- molecular sieves 4A can be
- the reaction temperature is usually from 150 ° C to 40 ° C.
- the reaction time is generally 1 hour to 24 hours, preferably 4 hours.
- the target compound (LVI I) of this reaction is collected from the reaction mixture according to a conventional method. For example, after neutralizing the reaction mixture, concentrating, adding a water-immiscible organic solvent such as ethyl acetate, washing with water, separating the organic layer containing the target compound, drying over anhydrous magnesium sulfate, etc., and removing the solvent. Obtained by distillation.
- the obtained compound (LVI I) can be purified, if necessary, by a conventional method, for example, recrystallization, silica gel chromatography and the like.
- step Aa8 compound (LVI I) is converted to phosphite and further oxidized to produce compound (LXI II), which is reacted under the same conditions as in step Aa8. This is achieved by:
- the protecting group (R ′, R 2 , R 3 and R 4 ) of the compound (LVI II) has a double bond
- the protecting group is preferably an aryl group or an aryloxycarbonyl group.
- the protecting group is an aralkyl group and R ", R 2 , R 3 and R 4 have no double bond, deprotection by hydrogenolysis in an inert solvent, in the presence of a catalyst, and in a hydrogen atmosphere can do.
- solvent used examples include ethers such as tetrahydrofuran, dioxane and ether; esters such as ethyl acetate; alcohols such as methanol and ethanol; formic acid and acetic acid.
- Organic acids may be mentioned, preferably ethanol.
- the catalyst used may be, for example, palladium / "carbon, palladium hydroxide And palladium hydroxide / carbon, and palladium black.
- Palladium hydroxide is preferably used.
- the reaction temperature is usually from 0 ° C to 50 ° C, preferably from 5 ° C to 25 ° C.
- the reaction time is generally 1 to 48 hours, preferably 3 to 24 hours.
- the target compound (la) of this reaction is collected from the reaction mixture according to a conventional method. For example, it can be obtained by filtering off the catalyst from the reaction mixture and concentrating the obtained filtrate.
- the obtained compound can be purified by a conventional method, for example, recrystallization, silica gel chromatography or the like.
- protecting groups are phenyl groups, R ', when R 2, R 3 and R 4 without double bond, in an inert solvent, the presence of a catalyst, by catalytic reduction, be deprotected it can.
- solvent used examples include ethers such as tetrahydrofuran, dioxane and ether; esters such as ethyl acetate; alcohols such as methanol and ethanol; formic acid and acetic acid.
- ethers such as tetrahydrofuran, dioxane and ether
- esters such as ethyl acetate
- alcohols such as methanol and ethanol
- formic acid and acetic acid examples thereof include organic acids, and preferred is tetrahydrofuran.
- the catalyst used is preferably platinum oxide. .
- the reaction temperature is usually 0 ° C. to 50 ° C., and preferably 5 ° C. to 25 ° C.
- the reaction time is generally 1 to 48 hours, preferably 1 to 24 hours.
- the target compound (la) of this reaction is collected from the reaction mixture according to a conventional method. For example, it can be obtained by filtering off the catalyst from the reaction mixture and concentrating the obtained filtrate.
- the obtained compound can be purified, if necessary, by a conventional method, for example, recrystallization, cellulose chromatography or the like.
- the protecting group is an aryl group or an aryloxycarbonyl group
- reflux in 95% ethanol water with an inert solvent, a palladium catalyst, a formic acid-triethylamine mixture, a monotriethylamine acetate, or a rhodium catalyst By doing so, the aryl group or the aryloxycarbonyl group of the compound (LVIII) can be deprotected.
- the obtained compound can be purified, if necessary, by a conventional method, for example, recrystallization, cellulose chromatography or the like. (3-2) b method
- This method is a method for producing the present compound (lb) in which Q is an oxygen atom and R 5 is a hydroxyl group.
- This step is a step of subjecting compound (XXVI 1), (XXIX) or (LXX) to a glycosylation reaction with compound (XVIII) to produce compound (LIX), under the same conditions as in Step C all. It is achieved by reacting.
- This step is a step of producing a compound (LX) by converting the compound (LIX) into phosphite and further oxidizing the same, and is achieved by reacting under the same conditions as in the step Aa8. Is done.
- This step is a step of producing the compound (lb) of the present invention by deprotecting the protecting group of the compound (LX), and is achieved by reacting under the same conditions as in the step Ca3.
- the compound (XXXI II), (XXXVI II), (XLI II), (XUX), (LI I), (LVI) or (LXXIV) is subjected to a glycosylation reaction with the compound (XIV),
- This step is a step of producing the compound (I) of the present invention by deprotecting the protecting group of the compound (LXI), and is achieved by reacting under the same conditions as in Step Ca3. You.
- R 4 of the compound (LXI I) has the formula
- the compound (LXI I) is deprotected from the protecting group R "to produce the compound (LXI II).
- the compound (LXI I) is treated with 2,3-dichloromethane in an inert solvent. This can be achieved by reacting with 5,6-dicyano-1,4-benzoquinone (DDQ)-Examples of solvents used include halogenated hydrocarbons such as methylene chloride.
- the reaction temperature is usually from room temperature to 50 ° C.
- the reaction time is usually from 5 minutes to 24 hours.
- the target compound (LXIII) of the present invention is collected from the reaction mixture according to a conventional method.
- it can be obtained by diluting the reaction mixture with an inert solvent, washing with an aqueous alkali solution and water, drying over anhydrous magnesium sulfate or the like, and distilling off the solvent.
- the obtained compound can be purified by a conventional method, for example, recrystallization, silica gel chromatography, or the like.
- This step is a step of producing the compound (lc) of the present invention by deprotecting the protecting group of the compound (LXI II), and is achieved by reacting under the same conditions as in Step Ca3. .
- This method is a method for producing the present compound (Id) in which R 5 is a hydroxyl group. (Step C e 1)
- This step is a step of producing the compound (Id) of the present invention in which R 5 is a hydroxyl group by deprotecting the protecting group of the compound (LXXV), and by reacting under the same conditions as in the step Ca3. Achieved.
- This method is a method for producing a compound (LXXVIII) which is an intermediate for producing the compound of the present invention wherein Q is an oxygen atom.
- the compound (LXXVI) is subjected to a glycosylation reaction with the compound (XIV) to produce the compound (XXXI), and the reaction is carried out under the same conditions as in Step Ca1. Is achieved. (Cf 2 step)
- This step is a step of producing a compound (LXXVI II) by deprotecting the protecting group at the 1-position hydroxyl group of the compound (LXXVI I), and is accomplished by reacting under the same conditions as in the step Aal. .
- Examples of the dosage form of the compound (I) of the present invention include oral administration by tablets, capsules, granules, powders, syrups and the like, and parenteral administration by injections or suppositories. These preparations are produced by known methods using additives such as excipients, binders, disintegrants, lubricants, stabilizers, and flavoring agents.
- the amount used depends on the symptoms, age, etc., but it can be administered to adults in a daily dose of 0.01 to 10 mgZ kg once or several times a day. .
- the present invention will be described in more detail with reference to Examples, Reference Examples, and Test Examples, but the present invention is not limited thereto.
- the concentrate was diluted with ethyl acetate, and the solution was washed with water, saturated aqueous sodium hydrogen carbonate and saturated saline, dried over magnesium sulfate, filtered, and concentrated under reduced pressure.
- the reaction solution was diluted with methylene chloride, and the solution was washed with saturated aqueous sodium hydrogen carbonate, dried over magnesium sulfate, filtered, and concentrated under reduced pressure.
- the reaction solution was diluted with ethyl acetate, and the solution was washed with 10% hypo-water and saturated aqueous sodium hydrogen carbonate, dried over magnesium sulfate, filtered, and concentrated under reduced pressure.
- reaction solution was diluted with ethyl acetate, washed with water and saturated saline, dried over sodium sulfate, filtered, and concentrated under reduced pressure.
- Aryl 3-0-decyl-2-deoxy-1,4,6-propylidene-1 2- (3-year-old oxotetradecanoylamino) 1-j8-D-dal copyranoside obtained in (6) (1.310 g, 2.100 mmol) was dissolved in 80% aqueous acetic acid (100 mL), the solution was stirred at 60 C for 1 hour, and the reaction solution was concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (eluent: ethyl acetate, then ethyl acetate containing 5% methanol) to give the title compound (1.100 g, yield 90 °!).
- Decanoylamino) - ⁇ — D darcoviranoside (315) obtained from (8) mg, 0.451 mmol) in THF (10 m), and lr [C 8 H, 2 (MePh 2 P) 2 ] PF 6 (5 mg) activated with hydrogen was added to this solution. The mixture was stirred at room temperature for 3 hours and concentrated under reduced pressure to give the title compound quantitatively.
- reaction solution was diluted with methylene chloride, washed with water and aqueous sodium hydrogen carbonate, dried over magnesium sulfate, filtered, and concentrated under reduced pressure.
- reaction solution was diluted with methylene chloride, washed with aqueous sodium hydrogen carbonate and saturated saline, dried over magnesium sulfate, filtered, and concentrated under reduced pressure.
- Diarylphosphono 4 O— (aryloxycarbonyl) 1-3 —O—decyl-2-deoxyxy 6-0- ⁇ 4-0—diarylphosphono-3-0-[(R) _ obtained from (13) 3 —methoxydecyl] 1 6 — O—methyl-2 — O— [(Z)-1 1 year old kutadecenoyl] -1 ⁇ — D-darcopyranosyl ⁇ -1 2 — (3 year old xotetradecanoylamino) ⁇ — Dissolve D-darcoviranoside (95 mg, 0.061 mmol) in dry THF (5 mlj) and add triphenylphosphine (11 mg, 0.042 mmol), triethylamine (43 mg, 0.425 mmol), formic acid (36 mg) to this solution.
- Example 1 using -O-[(R) 13-methoxydidecyl] 1 6-1 0-methyl-2—0 — [(Z) —11—tactadecenyl] — ⁇ , / ⁇ —D-Darcovyranoside
- the same reaction as in (2) was carried out to obtain the title compound as an oil (yield: 75%).
- Wood 3 3 O—decyl 2—decyl 6—O— ⁇ 3—0 — [(R) —3—methoxydecyl] —2—0 — [(Z) -1 1 1 year old Kutadecenol] — 4-10—Phosphono-1-D-Darcovyranosyl ⁇ — 2— (3-Oxotetradecanoylamino) ⁇ -D-Darcovyranoside (Compound No. 3)
- reaction solution was diluted with methylene chloride, washed with aqueous sodium bicarbonate and brine, dried over magnesium sulfate, filtered, and concentrated under reduced pressure
- the resulting residue was purified by silica gel chromatography-(elution solvent: cyclohexane acetic acid) Purification with ethyl-4 / 1) gave 0.52 g of an anomeric mixture of the title compound as an oil (90% yield). A part of the mixture could be separated into ⁇ -anomer and i3-anomer using silica gel thin layer chromatography. ,
- IR f i lm 3324, 2927, 2856, 1750, 1460 cm.
- Diarylphosphono 4 O— (Aryl xylon) 1 3 — O 1 Decyl 2 — Dexyl 6 — 0— ⁇ 6-0-(Aryl xycarbonyl) — 4 0 0 —Diarylphosphono 3 — 0 — [(R) -3—Methoxyxidyl] —2—0 — [(Z) 1-111—Kitadecenoyl]; ⁇ —D—Darcoviranosyl ⁇ 1-2— (3—Kisotetradecanoyla Mino) ⁇ -D-Darcovyranoside (C a 2 step)
- Diarylphosphono 4-1 0— (Aryl xycarbonyl) — 3— O 1 decyl— 2—Dyxy 6—0— ⁇ 6—0— (Aryl xycarbonyl) 1—4 0— Diarylphosphonol 3—0 — [(R) —3-Methoxydecyl] 1 2—0 — [(Z) —1 1—Decenyl decenyl] 1—D—Darcarcanolanosyl ⁇ -2-(3— Akisotetra Ladecanoylamino) ⁇ -D-Darcovyranoside (Step C a 2)
- reaction solution was diluted with ethyl acetate, and the solution was washed with saturated aqueous sodium hydrogen carbonate and saturated brine, dried over magnesium sulfate, filtered, and concentrated under reduced pressure to obtain crude aldehyde (16.47 g). ).
- the resulting crude aldehyde was dissolved in 99.5 ethanol (300 mL), sodium borohydride (NaBH 4, 2.00 g) was stirred at room temperature for 20 minutes added. After the completion of the reaction, acetic acid was added to the reaction solution under ice cooling to decompose NaBH 4 and concentrated under reduced pressure. Dissolve the concentrate in ethyl acetate, wash the solution with saturated aqueous sodium bicarbonate and saturated saline, dry over magnesium sulfate, filter, and concentrate under reduced pressure to mix the alcohol amide and amine. (Approximately 9.0 g).
- IR film 3400-3200, 2926, 2855, 1751, 1669, 1651, 1547, 1461 cm "'.
- reaction solution was concentrated under reduced pressure, and the resulting concentrate was dissolved in DMF (30 mL) and 2,2-dimethoxypropane (dissolved in 30 m to give p- Toluenesulfonic acid monohydrate (500 mg) was added, and the mixture was stirred at room temperature for 16 hours.
- the reaction solution was diluted with ethyl acetate, washed with aqueous sodium bicarbonate and saturated saline, and washed with magnesium sulfate.
- the residue obtained was dried, filtered, and concentrated under reduced pressure, and the resulting residue was subjected to silica gel chromatography (elution solvent: cyclohexanenoacetic acid ethyl ester).
- the aryl 3 0-decyl—4, 6—0—isopropylidene-a,; 8—D-darcoviranoside (anomer 3: 1 mixture, 300 mg, 0.750 tnmol) obtained in (2) was converted to methylene chloride—THF ( 2: 1, 6 m, and 3-oxotetradecanoic acid (242 tng, 1.00 mmo I) and WSC I hydrochloride (192 mg, 1 ⁇ 000 mmo I) were added to the solution, and the mixture was stirred at room temperature for 1 hour.
- reaction solution was diluted with methylene chloride, washed with water and aqueous sodium hydrogen carbonate, dried over magnesium sulfate, filtered, and concentrated under reduced pressure.
- Aryl 3-0-decyl-4,6-0-isopropylidene 1-2-0- (3-year-old oxotetradecanoyl) -1a, j8-D-Darcovyranoside (3: 1 mixture of anomers, 2.37) obtained in (3) g, 3.793) were dissolved in methanol (35 m), and P-toluenesulfonic acid (200 mg) was added to the solution, followed by stirring at room temperature for 2 hours.
- IR film 3430 2925, 2855, 1754 1719, 1650 (w), 1466 en)-'.
- the obtained wood sulfate was dissolved in THF (8 m), and a 30 ⁇ ⁇ aqueous solution of hydrogen peroxide (0.55 m) was added to the solution, and the mixture was stirred for 30 minutes under ice cooling. After the reaction was completed, the reaction solution was diluted with ethyl acetate. The residue was washed with 10% aqueous sodium sulfate and saturated saline, dried over magnesium sulfate, filtered, and concentrated under reduced pressure. The resulting residue was purified by silica gel column chromatography (elution solvent: cyclohexane / acetic acid). The title compound (263 mg, yield 573 ⁇ 4) was obtained by purification with ethyl acetate.
- the reaction solution was filtered, concentrated under reduced pressure, and filled with 6 g of DEAE-cell mouth.
- the purified product was purified by column (eluent: 0.05 mol / L ammonium acetate solution of chloroform-methanol-water (2: 3: 1)) to obtain the desired fraction.
- the lower form-form layer was collected and concentrated under reduced pressure to obtain an octopus-like title compound (46 mg, yield 54%).
- the reaction mixture was diluted with methylene chloride, washed with aqueous sodium bicarbonate and saturated saline, and dried over magnesium sulfate.
- Diarylphosphono 4-0 arylaryl xycarbone 3 — 0—decyl—6—0— [6—0—aryloxycarbonyl 2—4—0—diarylphosphonol 3—0 — [(R) 1-Methoxydecyl] — 2 — 0-[(Z) 1 ⁇ 1 year old decadenoyl] — ⁇ — D-Darcopyranosyl] — 2 — 0— (3-year old xotetradecanoyl) ⁇ -D-Darcovyranoside (No. C a 2 process)
- reaction solution was diluted with ethyl acetate, washed with aqueous sodium bicarbonate and saturated saline, dried over magnesium sulfate, filtered, and concentrated under reduced pressure.
- Example 10 (120 tng, 0.081 mmol) was reacted in the same manner as in Example 10 (2) to obtain a title compound in the form of a ribbon (90 mg, yield: 843 ⁇ 4).
- reaction solution was filtered, concentrated under reduced pressure, and a column packed with 8 g of DEAE-cellulose (elution solvent: chloroform-methanol-water (2: 3: 1) in 0.05 mol / L ammonium acetate).
- DEAE-cellulose extraction solvent: chloroform-methanol-water (2: 3: 1) in 0.05 mol / L ammonium acetate.
- the desired product fraction can be obtained by purification in The fractions were collected, and the mixture was added to a mixture of mouth-form-methanol-water 0: 1: 1), and the mixture was stirred with a separatory funnel. The form layer was collected and concentrated under reduced pressure to give the title compound (90 mg, yield 755) in the form of a triangle.
- reaction solution was diluted with methylene chloride, washed with aqueous sodium hydrogen carbonate and saturated saline: C, dried over magnesium sulfate, filtered, and concentrated under reduced pressure.
- diarylphosphono 4 O—aryl — xyponyl — 2 — O— [(R) -3-((aryl) xycarbonyl) tetradecyl] — 3 — O— dodecyl 6 — 0— ⁇ 4 — 0—Diarylphosphono—3—0 — [(R) -1-3—Methoxyxyl] -1-6-O—methyl—2—0 — [(Z) —11 1-year-old cutadecenyl] — ⁇ -D_Dalcopyranosyl ⁇ —a , ⁇ — D-Darcovyranoside (C a 2 step)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Transplantation (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0506671-9A BRPI0506671A (pt) | 2004-01-08 | 2005-01-07 | análogo de levulose glicose-lipìdio |
EP05703673A EP1702926A4 (en) | 2004-01-08 | 2005-01-07 | LEVULOSEGLUCOSELIPID-A-ANALOG |
US10/585,640 US20090062214A1 (en) | 2004-01-08 | 2005-01-07 | Left-Side Glucose Lipid a Analogue |
CA2552218A CA2552218C (en) | 2004-01-08 | 2005-01-07 | Left-side glucose lipid a analogue |
CN2005800074292A CN1930180B (zh) | 2004-01-08 | 2005-01-07 | 左侧葡萄糖脂a类似物 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004002902 | 2004-01-08 | ||
JP2004-002902 | 2004-01-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005066193A1 true WO2005066193A1 (ja) | 2005-07-21 |
Family
ID=34747064
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2005/000434 WO2005066193A1 (ja) | 2004-01-08 | 2005-01-07 | 左糖グルコースリピドa類縁体 |
Country Status (8)
Country | Link |
---|---|
US (1) | US20090062214A1 (ja) |
EP (1) | EP1702926A4 (ja) |
KR (1) | KR20060121293A (ja) |
CN (1) | CN1930180B (ja) |
BR (1) | BRPI0506671A (ja) |
CA (1) | CA2552218C (ja) |
TW (1) | TW200530260A (ja) |
WO (1) | WO2005066193A1 (ja) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10324694A (ja) * | 1997-03-25 | 1998-12-08 | Sankyo Co Ltd | リピッドa1位カルボン酸誘導体 |
JP2001348396A (ja) * | 2000-04-06 | 2001-12-18 | Sankyo Co Ltd | リピッドa1位カルボキシメチル類縁体 |
WO2003106473A1 (ja) * | 2002-06-18 | 2003-12-24 | 三共株式会社 | グルコシルリピッドa1位カルボキシメチル類縁体 |
JP2004217630A (ja) * | 2002-12-24 | 2004-08-05 | Sankyo Co Ltd | 右糖グルコースリピドa類縁体 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5750664A (en) * | 1995-06-05 | 1998-05-12 | Eisai Co., Ltd. | Substituted liposaccharides useful in the treatment and prevention of endotoxemia |
IL144706A0 (en) * | 1999-02-10 | 2002-06-30 | Sankyo Co | Ether type lipid a-1 carboxylic acid analogue and pharmaceutical compositions containing the same |
-
2005
- 2005-01-07 KR KR1020067013689A patent/KR20060121293A/ko not_active Application Discontinuation
- 2005-01-07 WO PCT/JP2005/000434 patent/WO2005066193A1/ja active Application Filing
- 2005-01-07 CA CA2552218A patent/CA2552218C/en not_active Expired - Fee Related
- 2005-01-07 TW TW094100470A patent/TW200530260A/zh unknown
- 2005-01-07 EP EP05703673A patent/EP1702926A4/en not_active Withdrawn
- 2005-01-07 BR BRPI0506671-9A patent/BRPI0506671A/pt not_active IP Right Cessation
- 2005-01-07 CN CN2005800074292A patent/CN1930180B/zh not_active Expired - Fee Related
- 2005-01-07 US US10/585,640 patent/US20090062214A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10324694A (ja) * | 1997-03-25 | 1998-12-08 | Sankyo Co Ltd | リピッドa1位カルボン酸誘導体 |
JP2001348396A (ja) * | 2000-04-06 | 2001-12-18 | Sankyo Co Ltd | リピッドa1位カルボキシメチル類縁体 |
WO2003106473A1 (ja) * | 2002-06-18 | 2003-12-24 | 三共株式会社 | グルコシルリピッドa1位カルボキシメチル類縁体 |
JP2004217630A (ja) * | 2002-12-24 | 2004-08-05 | Sankyo Co Ltd | 右糖グルコースリピドa類縁体 |
Non-Patent Citations (2)
Title |
---|
HOMMA J.Y. ET AL: "Structural Requirements of Lipid A Responsible for the Functions: A Study with Chemically Synthesized Lipid A and Its Analogues", THE JOURNAL BIOCHEMISTRY, vol. 98, no. 2, 1985, pages 395 - 406, XP002975864 * |
See also references of EP1702926A4 * |
Also Published As
Publication number | Publication date |
---|---|
TW200530260A (en) | 2005-09-16 |
CN1930180A (zh) | 2007-03-14 |
EP1702926A1 (en) | 2006-09-20 |
US20090062214A1 (en) | 2009-03-05 |
BRPI0506671A (pt) | 2007-05-15 |
KR20060121293A (ko) | 2006-11-28 |
CN1930180B (zh) | 2010-05-26 |
EP1702926A4 (en) | 2010-03-17 |
CA2552218C (en) | 2010-06-22 |
CA2552218A1 (en) | 2005-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9309276B2 (en) | Synthetic lipid A derivative | |
US6113918A (en) | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors | |
US6355257B1 (en) | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors | |
US6303347B1 (en) | Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors | |
RU2481352C2 (ru) | Функционализированные бета 1,6 глюкозамин-дисахариды и способ их получения | |
WO2005066193A1 (ja) | 左糖グルコースリピドa類縁体 | |
JP2710900B2 (ja) | 酸性官能基を有する脂質誘導体及び同誘導体によって被覆された微粒子キャリヤー | |
WO2012121617A1 (en) | Oligosaccharide compounds | |
JP2004217630A (ja) | 右糖グルコースリピドa類縁体 | |
JP2005220130A (ja) | 左糖グルコースリピドa類縁体 | |
JP2007039450A (ja) | 左糖グルコースリピドa類縁体を含有する医薬 | |
Ohira et al. | The chemoselective O-glycosylation of alcohols in the presence of a phosphate diester and its application to the synthesis of oligomannosylated phosphatidyl inositols | |
Ogawa et al. | Synthesis and immunoadjuvant activity of the conjugates of 1-thio-N-acetyl-muramoyl dipeptide with lipid A subunit analogs | |
MXPA06007822A (en) | Levulose glucoselipid a analogue | |
JP2766141B2 (ja) | 酸性糖誘導体 | |
WO2004058788A1 (ja) | 右糖グルコースリピドa類縁体 | |
JP2839921B2 (ja) | リピドaモノサッカライド類縁体 | |
JP2001348396A (ja) | リピッドa1位カルボキシメチル類縁体 | |
HU217114B (hu) | Új monoszacharidszármazékok, ilyen vegyületeket tartalmazó gyógyászati készítmények és eljárás ezek előállítására | |
WO2000047595A1 (fr) | Analogues de type ether d'acide a1-carboxylique lipidique | |
WO2003106473A1 (ja) | グルコシルリピッドa1位カルボキシメチル類縁体 | |
JP2006008539A (ja) | 右糖グルコースリピドa類縁体を含有する医薬組成物 | |
WO2001077133A1 (fr) | Analogues 1-carboxymethyl du lipide a | |
JP2000095694A (ja) | 新規な医療用薬剤 | |
JP2003176229A (ja) | リピッドa1位カルボキシメチル類縁体を有効成分として含有する医薬 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005703673 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2552218 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020067013689 Country of ref document: KR Ref document number: PA/a/2006/007822 Country of ref document: MX |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200580007429.2 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2005703673 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020067013689 Country of ref document: KR |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |
|
ENP | Entry into the national phase |
Ref document number: PI0506671 Country of ref document: BR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10585640 Country of ref document: US |